CD8A and prostate carcinoma: These data were in line with our recent study where samples from SARS‐CoV‐2‐unexposed donors or prostate cancer patients were also largely not enriched with SARS‐CoV‐2 spike glycoprotein‐specific CD8+ T cells.31